BioPharma Credit PLC (BPCR) — Defensive Interval Ratio
BioPharma Credit PLC (BPCR) has a Defensive Interval Ratio of 2640 days as of June 2025. Defensive assets of $54.21 Million (cash $-, short-term investments $-, receivables $54.21 Million) cover 2640 days of daily cash needs of $20.53K/day. See BPCR working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
BioPharma Credit PLC Defensive Interval Ratio (2017–2024)
This chart shows how BioPharma Credit PLC's Defensive Interval Ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 2640 days, meaning defensive assets of $54.21 Million can fund 2640 days of operations without new revenue. See BPCR equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for BioPharma Credit PLC (2017–2024)
The table below presents the year-by-year Defensive Interval Ratio for BioPharma Credit PLC from 2017 to 2024, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BioPharma Credit PLC stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 649 days | $31.80 Million | $49.00K/day | $- | $- | ▼ -940 days |
| 2023 | 1589 days | $69.08 Million | $43.48K/day | $- | $48.85 Million | ▲ +1313 days |
| 2022 | 275 days | $19.84 Million | $72.06K/day | $- | $- | ▼ -301 days |
| 2021 | 576 days | $10.01 Million | $17.38K/day | $- | $- | ▲ +576 days |
| 2020 | 0 days | $3.00K | $25.73K/day | $- | $- | ▼ -241 days |
| 2019 | 241 days | $16.21 Million | $67.13K/day | $- | $- | ▼ -1193 days |
| 2018 | 1435 days | $21.45 Million | $14.95K/day | $- | $- | ▲ +844 days |
| 2017 | 591 days | $4.72 Million | $7.99K/day | $- | $- | — |